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Summary
QUESTION UNDER STUDY: To test longitudinally dif-
ferences in conventional cigarette use (cigarettes smoked,
cessation, quit attempts) between vapers and nonvapers.
METHODS: Fifteen months follow-up of a sample of
5 128 20-year-old Swiss men. The onset of conventional ci-
garette (CC) use among nonsmokers, and smoking cessa-
tion, quit attempts, changes in the number of CCs smoked
among smokers at baseline were compared between vapers
and nonvapers at follow-up, adjusted for nicotine depend-
ence.
RESULTS: Among baseline nonsmokers, vapers were
more likely to start smoking at follow-up than nonvapers
(odds ratio [OR] 6.02, 95% confidence interval [CI] 2.81,
12.88 for becoming occasional smokers, and OR = 12.69,
95% CI 4.00, 40.28 for becoming daily smokers). Vapers
reported lower smoking cessation rates among occasional
smokers at baseline (OR = 0.43 (0.19, 0.96); daily smokers:
OR = 0.42 [0.15, 1.18]). Vapers compared with nonvapers
were heavier CC users (62.53 vs 18.10 cigarettes per week,
p <0.001) and had higher nicotine dependence levels (2.16
vs 0.75, p <0.001) at baseline. The number of CCs smoked
increased between baseline and follow-up among occasion-
al smokers (b = 6.06, 95% CI 4.44, 7.68) and decreased
among daily smokers (b = –5.03, 95% CI –8.69, –1.38),
but there were no differential changes between vapers and
nonvapers. Vapers showed more quit attempts at follow-up
compared with nonvapers for baseline occasional smokers
(incidence rate ratio [IRR] 1.81, 95% CI 1.24, 2.64; daily
smokers IRR 1.28, 95% CI 0.95, 1.73).
CONCLUSIONS: We found no beneficial effects of vaping
at follow-up for either smoking cessation or smoking re-
duction.
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Introduction
As pointed out by Grana, et al. [1], the USA patent de-
scribes e-cigarettes (ECs) as a substitution for cigarettes
to help smokers quit smoking. In the past few years, ECs
have quickly penetrated the market in established market
economies [1, 2]. Such an increasing prevalence opened a
heated debate on the pros and cons of EC use [3–5]. Four
major concerns were raised and discussed [3, 4]:
a) the safety of EC use and its potential effects on health;
b) there may be limited evidence that EC use actually
helps smokers quit smoking;
c) the widespread use of ECs may “renormalise” smoking,
which may increase the smoking prevalence, or slow
down its decrease;
d) EC use may act as a gateway to conventional cigarette
(CC) use.
The claim that longitudinal studies are lacking is common
in debates on EC use. In a recent review [1], only four
population-based longitudinal studies on smoking cessa-
tion and EC use were found [6–9]. These studies have
been criticised, among other things, for not accounting for
the level of nicotine dependence or not including subjects
who may have quit smoking as a result of EC use [4, 5].
The present study looks at longitudinal changes in smoking
status, quit attempts, and the number of cigarettes smoked
by young male vapers (“EC users” and “vapers” are used
interchangeably, “smokers” referring to users of CCs) ad-
justed for nicotine dependence.
There is now consensus that, although EC use is not safe,
it is less harmful than CC use [4, 10–12]. Therefore, the
question whether the use of ECs reduces the use of CCs,
including smoking cessation, is fundamental. This argu-
ment faces the counter-argument that EC use in many stud-
ies was most prevalent among CC users, otherwise known
as “dual users” [1]. However, this does not mean per se
that EC use has a negative impact on health, provided that
dual users reduce their CC use in favour of EC use [4,
5]. A review confirmed that EC use is likely to reduce the
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number of CCs smoked, but that vapers are less likely to
quit smoking than nonvapers [1]. However, only reducing
the number of smoked cigarettes may have little beneficial
value for reducing toxicant exposure, because of compens-
atory smoking, e.g. by taking longer puffs or inhaling more
deeply [13]. The studies included in this review have been
criticised for design issues [5] and for not adjusting for
nicotine dependence [4]. A recent real-world experiment
[2] showed – adjusting for nicotine dependence – that EC
use results in more quit attempts and continued abstinen-
ce than with nicotine replacement therapy products bought
over the counter or without any aid. Another recent longit-
udinal study adjusting for nicotine dependence found a sig-
nificant increase in the number of CCs smoked and a lower
likelihood of quitting smoking among vapers compared
with nonvapers [14]. However, studies have also shown
that EC use may be positively associated with attempts to
quit smoking CCs [15]. Hence, findings are still heterogen-
eous and more longitudinal studies are needed.
Another concern is that, because there is a growing aware-
ness and an increase in the first use of ECs among young
people [11], EC use may lead to a renormalisation of CC
use or act as a gateway into CC use. This view has been
criticised for mainly three reasons: (a) EC use is still rare
nowadays among young people, (b) smoking prevalence
rates continue to decrease despite the increasing use of ECs
in some countries, and (c) ECs are mainly used by current,
mostly heavy CC users [5]. This critique has been suppor-
ted, amongst others, by a study in 10–16-year-olds in Wales
[16], which showed that CC use became increasingly com-
mon, but that regular EC use was uncommon and mainly
associated with current cigarette smoking as well as can-
nabis use. Nevertheless, other studies found that EC use in-
creased, even among young nonsmokers, e.g. in the USA
[17]. Moreover, strong increases in EC and CC use have
been found among 15–19-year-olds in Poland [18], not re-
flecting the substitution of CCs for ECs.
The present study followed-up men aged 20 years at
baseline over a period of around 15 months. It examined
the following research questions:
a) Is vaping compared with nonvaping associated with
higher follow-up smoking rates among baseline
nonsmokers?
b) Is vaping compared with nonvaping associated with
higher follow-up cessation rates among baseline
smokers?
c) Is vaping compared with nonvaping associated with
fewer cigarettes used at follow-up among smokers?
d) Is vaping compared with nonvaping among smokers as-
sociated with more attempts to quit smoking?
Methods
Study design and participants
The data used in the present study are part of the Cohort
Study on Substance Use Risk Factors (C-SURF). The re-
search protocol (15/07) has been approved by the ethics
committee for clinical research of Lausanne University
Medical School. In Switzerland, the army recruitment pro-
cedure is mandatory for young males: all 20-year-old males
must report to one of the six Swiss army recruitment
centres to determine their eligibility for military or civil
service. Enrolment took place in three of six army recruit-
ment centres, covering twenty-one of the twenty-six Swiss
cantons. Although the tasks of informing and enrolling par-
ticipants to the study took place in the army recruitment
centres, the study was kept independent of the army. Be-
cause questionnaires were completed at home, participants
were not influenced by army procedures when filling out
questionnaires.
A total of 7556 participants gave written consent to par-
ticipate and, among them, 5987 (79.2%) completed the
baseline questionnaire between September 2010 and March
2012, and 6020 (79.7%) completed the follow-up ques-
tionnaire between March 2012 and April 2013. A total
of 5,479 (91.5% of baseline respondents) completed both
the baseline and follow-up questionnaires. As the standard
method of assessment, online questionnaires were used,
participants were provided via email with an individualised
link to an online questionnaire, but participants could re-
ceive a paper and pencil version upon request. Missing val-
ues were listwise deleted. The final analytical sample com-
prised 5128 respondents (93.6% of respondents to baseline
and follow-up). More information on the enrolment pro-
cedure as well as on nonparticipation has been described
in previous studies [19, 20]. In short, differences between
nonconsenters, nonrespondents and respondents were com-
monly small and sometimes in different directions. For ex-
ample, respondents more often consumed alcohol (93.7%)
compared with the total population including nonrespond-
ents and nonconsenters (92.6%). However, respondents
were less often smokers (37.8%) and cannabis users
(32.5%) compared with the total population (46.2% vs
34.3%).
Measures
E-cigarette use
At follow-up, participants were asked whether they had
used ECs in the previous 12 months. The use of ECs differ-
entiated between 12-month vapers and nonvapers.
Conventional cigarette use
At baseline and follow-up, participants were asked whether
they had smoked cigarettes in the previous twelve months.
Questions on the frequency of smoking and the number of
cigarettes smoked on a typical smoking day were used to
differentiate between 12-month cigarette nonsmokers, oc-
casional (less than daily) smokers, daily smokers, and the
weekly number of cigarettes smoked.
Number of attempts to stop smoking
At follow-up, CC smokers were asked whether and how
many times they had attempted to stop smoking. Possible
responses were zero, one, two, three and four or more at-
tempts. Quit attempts were defined as seriously trying to
stop smoking and not smoking during several consecutive
days.
Nicotine dependence
At baseline and follow-up, nicotine dependence was as-
sessed with the Fagerström Test for Nicotine Dependence
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[21]. The continuous score ranging from 0 –“no symptom
of dependence” – to 10 – “high number of symptoms of
nicotine dependence” – was used.
Covariates
Sociodemographic variables, including age and the highest
completed level of education, were assessed at baseline
and follow-up. The highest completed level of education
consisted of three categories of schooling: primary school-
ing (9 years); vocational training (>9–12); post-secondary
schooling (13 years or more, including high school, which
can be only twelve years in some cantons). The linguistic
region differentiated between French- and German-speak-
ing participants.
Statistical analyses
Crude statistics to characterise vapers and nonvapers used
χ2- and t-tests. Multinomial logistic regressions models,
stratified by baseline cigarette smoking status (non-
smokers, occasional smokers, daily smokers) were conduc-
ted to test the associations between EC use and cigarette
smoking status (non-smokers, occasional smokers, daily
smokers) at follow-up. Three models were run: the unad-
justed model 1 tested the bivariate associations of EC use,
model 2 adjusted for baseline covariates, and model 3 ex-
amined the associations of EC use adjusting for baseline
covariates and baseline nicotine dependence. A series of
linear mixed models, stratified by baseline cigarette
smoking status (non-smokers, occasional smokers, daily
smokers), were conducted to test whether changes between
baseline and follow-up in the weekly number of cigarettes
smoked and whether nicotine dependence differed between
vapers and nonvapers. Model 1 tested EC use (vapers vs
nonvapers) as the between-subject factor, time of assess-
ment (follow-up vs baseline) as the within-subject factor,
and the interaction between EC use and time of assessment.
Time of assessment tested changes among nonvapers and
the interaction tested the difference in changes between
nonvapers and vapers. Model 2 additionally adjusted for
covariates, and model 3 additionally adjusted for nicotine
dependence. The association between EC use and the num-
ber of quit attempts was tested using negative binomial re-
gression models. The same three models as those specified
for multinomial logistic regressions were used.
C-SURF was not designed to test particular hypotheses on
EC use, but to enrol as many participants as possible over
the course of a year to test a multitude of hypothesese about
addictive behaviours [22]. Nevertheless, with regard to the
sample size, we estimated that for a type 1 error of 5% and
a power of 80%, 4221 participants would be needed to de-
tect an odds ratio (OR) of 1.5. This OR corresponds to a
small effect size [23, 24] under the assumption that the re-
sponse probability (e.g. for rare prevalence rates such as
illicit drug use) is around 5%, and the independent vari-
ables of interest (e.g. EC use) is correlated with control
variables (here age, highest achieved education, linguist-
ic region) with an R2 = 0.20. Thus, the sample size was
more than sufficient to test small effect sizes given that the
prevalence rates of the corresponding dependent variables
(e.g., smoking status) were much higher. Pass 11 (NCSS,
Kaysville, Utah, USA. http://www.ncss.com), using the al-
gorithm described by Hsieh et al. [24], was used to calcu-
late sample sizes.
Results
Descriptive characteristics of the total sample, vapers
and nonvapers
Descriptive characteristics of the total sample, vapers and
nonvapers, are reported in table 1. The mean age of par-
ticipants was 19.98 years at baseline and 21.31 years at
follow-up. Vapers were significantly older than nonvapers
by about 2–3 months.
The 12-month vaping prevalence at follow-up was 5.0%
(254 vapers and 4874 nonvapers). Out of the 2825 baseline
nonsmokers, only 32 were vapers at follow-up (1.1%).
Vapers were most often daily smokers, whereas nonvapers
were more often nonsmokers. CC use rates were signific-
antly higher (by more than three times) among vapers than
among nonvapers.
Association between e-cigarrette use and cigarette
smoking status at follow-up
Among baseline nonsmokers, those who were vapers at
follow-up were more likely to initiate smoking (50.0%)
and to become daily smokers (12.5%) by follow-up (table
2) than were baseline nonsmokers who were not vapers
(13.1%; 367/2793 initiated smoking and 1.7% became
daily smokers)). Among occasional baseline smokers, non-
vapers became more often nonsmokers and less often daily
smokers than vapers. Differences were smaller among
daily baseline smokers. Nevertheless, 6.5% of nonvapers
no longer smoked at follow-up, compared with 2.9% of
vapers.
Multinomial regression models (table 3) revealed that
among nonsmokers at baseline, vapers were 6 times more
likely to be occasional smokers and over 12 times more
likely to be daily smokers at follow-up (vs nonsmokers)
than nonvapers. Among occasional baseline smokers,
vapers (vs nonvapers) were less likely to be nonsmokers
(OR 0.43; 95% confidence interval [CI] 0.19, 0.96) and
about 2.3 times more likely to be daily smokers (vs oc-
casional smoker) at follow-up. Among daily smokers at
baseline, EC use was negatively associated with
nonsmoking at follow-up, but the association did not reach
significance. Findings from all three models (unadjusted,
adjusted for covariates, adjusted for covariates and nicotine
dependance) were substantially equivalent.
Change in weekly number of
cigarettes smoked and nicotine
dependence
For the weekly number of cigarettes smoked and levels
of nicotine dependence (table 4), mixed models were used
only for occasional and daily smokers at baseline, since
baseline nonsmokers by definition did not smoke and were
not nicotine dependent. However, vapers among
nonsmokers at baseline (table 2) smoked 10 times as many
cigarettes at follow-up (mean 21.97 cigarettes per week)
as nonvapers (mean 1.98 cigarettes per week, see table 2),
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t(2823) = 7.10, p<0.001). Similarly, among nonsmokers
at baseline, nicotine dependence scores at follow-up were
higher for vapers than nonvapers, t(2823) = 9.15, p<0.001.
Among baseline occasional smokers, the mixed model for
EC use indicated that vapers smoked on average an estim-
ated 9.88 more cigarettes (adjusted for control variables)
at baseline than nonvapers (model 3: b = 9.88, 95% CI
6.37, 13.40); the coefficient “b” is the difference between
those coded 1 (vapers) and those coded 0 (nonvapers),
when time of assessment and the interaction are 0, which
is the case for the baseline measurement. A significant ef-
fect of time of assessment indicated that nonvapers (coded
Table 1: Descriptive characteristics at baseline and follow-up of the total sample and of vapers and nonvapers (measured at follow-up only), Switzerland 2010–2013.
Baseline measures of smoking and
demographics
Follow-up measures of smoking and
demographics
Total Vapers at
follow-up
(n = 254)
Nonvapers at
follow-up
(n = 4 874)
Total Vapers at
follow-up
(n = 254)
Nonvapers at
follow-up
(n = 4 874)
n % n % n % p-
value
n % n % n % p-
value
Smoking status <0.001 <0.001
Nonsmoker 2825 55.1 32 12.6 2793 57.3 2 783 54.3 27 10.6 2756 56.5
Occasional smoker 1348 26.3 82 32.3 1266 26.0 1 273 24.8 72 28.3 1201 24.6
Daily smoker 955 18.6 140 55.1 815 16.7 1 072 20.9 155 61.0 917 18.8
Cigarette use
Weekly number of cigarettes (M, SD) 20.31 43.01 62.53 57.26 18.10 40.97 <0.001 22.29 44.03 65.68 58.43 20.02 41.94 <0.001
Nicotine dependence (M, SD) 0.82 1.63 2.16 2.21 0.75 1.57 <0.001 0.87 1.64 2.39 2.20 0.79 1.57 <0.001
Number of quit attempts (M, SD) – – – – – – 0.19 0.59 0.54 0.89 0.18 0.56 <0.001
Sociodemographics
Age (M, SD) 19.98 1.22 20.15 1.47 19.97 1.21 0.026 21.31 1.27 21.55 1.59 21.30 1.25 0.002
Education 0.068 <0.001
Primary 2495 48.7 128 50.4 2367 48.6 379 7.4 23 9.1 356 7.3
Secondary 1475 28.8 83 32.7 1392 28.6 2 342 45.7 148 58.3 2 194 45.0
Tertiary 1158 22.6 43 16.9 1115 22.9 2 407 46.9 83 32.7 2 324 47.7
Linguistic region
French-speaking 2 857 55.7 127 50.0 2730 56.0 0.060 – – –
M = mean; SD = standard deviation
Table 2: Smoking characteristics at baseline and follow-up of vapers and nonvapers (measured at follow-up only) as a function of cigarette smoking status at baseline,
Switzerland 2010–2013.
Vapers at follow-up Nonvapers at follow-up
Smoking baseline
measures
Smoking follow-up
measures
Smoking baseline
measures
Smoking follow-up
measures
Smoking status at baseline M/n SD/% M/n SD/% M/n SD/% M/n SD/%
Nonsmoker at baseline n = 32 n = 2 793
Smoking status at follow-up
Nonsmoker (n, %) – – 16 50.0 – – 2 426 86.9
Occasional smoker (n, %) – – 12 37.5 – – 320 11.5
Daily smoker (n, %) – – 4 12.5 – – 47 1.7
Weekly number of cigarettes (M, SD) – – 21.97 65.89 – – 1.98 14.34
Nicotine dependence (M, SD) – – 1.44 2.26 – – 0.21 0.72
Number of quit attempts (M, SD) – – 0.09 0.39 – – 0.03 0.22
Occasional smoker at baseline n = 82 n = 1 266
Smoking status at follow-up
Nonsmoker (n, %) – – 7 8.5 – – 277 21.9
Occasional smoker (n, %) – – 47 57.3 – – 804 63.5
Daily smoker (n, %) – – 28 34.1 – – 185 14.6
Weekly number of cigarettes (M, SD) 21.89 28.73 28.96 34.29 8.82 16.94 16.23 29.52
Nicotine dependence (M, SD) 0.77 1.34 0.82 1.26 0.51 0.98 0.61 1.17
Number of quit attempts (M, SD) – – 0.59 0.94 – – 0.30 0.75
Daily smoker at baseline n = 140 n = 815
Smoking status at follow-up
Nonsmoker (n, %) – – 4 2.9 – – 53 6.5
Occasional smoker (n, %) – – 13 9.3 – – 77 9.4
Daily smoker (n, %) – – 123 87.9 – – 685 84.0
Weekly number of cigarettes (M, SD) 100.70 46.29 97.24 48.12 94.61 49.85 87.83 52.24
Nicotine dependence (M, SD) 3.46 1.98 3.53 1.95 3.31 2.03 3.07 2.10
Number of quit attempts (M, SD) – – 0.61 0.92 – – 0.48 0.81
M = mean;SD =standard deviation
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0) smoked an estimated 6.06 more cigarettes at follow-up
than at baseline (model 3: b = 6.06, 95% CI 4.44, 7.68); “b”
indicates the change from baseline (coded 0) to follow-up
(coded 1), when EC use and the interaction are 0 which is
the case for nonvapers. The time of assessment by EC use
interaction did not reach significance, indicating that the
changes between follow-up and baseline assessments did
not statistically differ between vapers and nonvapers.
Among baseline daily smokers, the effect of EC use was
not significant. Nonvapers smoked fewer cigarettes at
follow-up than at baseline (model 3: b= –5.03, 95% CI
–8.69, –1.38). The time of assessment by EC use interac-
tion did not reach significance, indicating, together with the
nonsignificant effect of EC use, no evidence for a differen-
ce between vapers and nonvapers in the number of cigar-
ettes smoked at baseline and changes in the number of ci-
garettes smoked to follow-up.
With regard to nicotine dependence (model 2) among
baseline occasional smokers, vapers reported higher levels
(on average a difference of 0.24 points on the Fagerström
Test for Nicotine Dependence, adjusted for covariates) of
nicotine dependence than nonvapers (b = 0.24, 95% CI
0.02, 0.46), nicotine dependence increased significantly
among nonvapers (b = 0.12, 95% CI 0.02, 0.21) and there
was no difference between nonvapers and vapers (nonsig-
nificant interaction EC use by time of assessment).
No significant difference in nicotine dependence was found
between vapers and nonvapers among baseline daily
smokers (effect of EC use). Nicotine dependence changed
in unadjusted analysis (model 1) between baseline and
follow-up among baseline daily smokers (time of assess-
ment), but the change did not survive after adjusting for
covariates. Moreover, even in the unadjusted analysis, no
significant difference in change was found between vapers
and nonvapers (interaction).
Association between e-cigarette use and number of
attempts to stop smoking
Negative binomial regression models of the number of at-
tempts to stop smoking on the use of EC (table 5) showed
that vapers reported significantly more attempts than non-
vapers among baseline occasional smokers (model 3, in-
cidence rate ratio [IRR] 1.81, 95% CI 1.24, 2.64). Among
baseline daily smokers, the association was not significant
(IRR 1.28, 95% CI 0.95, 1.73). Unadjusted models and
models adjusting for demographics only produced substan-
tially equivalent results.
Discussion
To our knowledge, the present study is one of the rare lon-
gitudinal studies on smoking patterns among EC users in
early adulthood. The 5.0% prevalence of past 12-month
vaping was relatively low, compared with around 45% of
CC use. Vapers were more likely to be smokers and partic-
ularly heavy smokers, as has been shown in many studies
(see [1] for review). EC users in the present study showed
higher nicotine dependence scores and smoked more cigar-
ettes, so they did have other smoking patterns than non-
vapers, a dimension often neglected in other studies. The
finding of the present study that vapers have more smoking
quit attempts than nonvapers supported the finding of other
studies that ECs are used as an aid to quit smoking [6, 25].
However, even adjusting for nicotine dependence, vapers
were less likely to quit smoking than nonvapers.
Before further discussing the findings of the present study,
one main caveat has to be mentioned. We measured EC use
at follow-up only, a design that is common in the literat-
ure, but that has been criticised [5]. Thus, we do not know
whether vapers actually became vapers between baseline
and follow-up or were vapers already at baseline. Theoret-
ically, it may also be that some former smokers at baseline
have stopped smoking already at baseline by using ECs.
Unfortunately, there are no data currently available about
the increase of vaping in Switzerland. Anecdotal evidence
from the market leader in EC sales or from incidental pois-
oning of little children with EC liquids in Switzerland sug-
gests that, whereas EC use was almost nonexistent in 2010,
it increased strongly thereafter. This suggests that the large
majority of vapers in the present study started to use ECs
after baseline assessment. Nevertheless, we cannot claim,
for example, that EC use initiated CC use or led to an in-
Table 3: Results of multinomial regression models of cigarette smoking status at follow up on e-cigarette use (measured at follow-up only), stratified by cigarette smoking
at baseline, Switzerland 2010–2013.
Smoking status at follow-up
Model 1 Model 2 Model 3
Nonsmoker Occasional
smoker
Daily smoker Nonsmoker Occasional
smoker
Daily smoker Nonsmoker Occasional
smoker
Daily smoker
Odds ratio
(95% CI)
Odds ratio
(95% CI)
Odds ratio
(95% CI)
Odds ratio
(95% CI)
Odds ratio
(95% CI)
Odds ratio
(95% CI)
Odds ratio
(95% CI)
Odds ratio
(95% CI)
Odds ratio
(95% CI)
Nonsmoker at baseline
E-cigarette use ref. 5.69
(2.67, 12.13)
12.90
(4.16, 40.07)
ref. 5.92
(2.76, 12.66)
11.38
(3.61, 35.89)
ref. 6.02
(2.81, 12.88)
12.69
(4.00, 40.28)
Occasional smoker at baseline
E-cigarette use 0.43
(0.19, 0.97)
ref. 2.59
(1.58, 4.24)
0.43
(0.19, 0.97)
ref. 2.47
(1.50, 4.07)
0.43
(0.19, 0.96)
ref. 2.31
(1.38, 3.86)
Daily smoker at baseline
E-cigarette use 0.42
(0.15, 1.18)
0.94
(0.51, 1.74)
ref. 0.42
(0.15, 1.17)
0.92
(0.52, 1.71)
ref. 0.42
(0.15, 1.18)
0.99
(0.52, 1.86)
ref.
CI = confidence interval
Model 1 = e-cigarette
Model 2 = model 1 adjusted for age, highest achieved education, linguistic region
Model 3 = model 2 adjusted for nicotine dependence.
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Table 4: Results of mixed models for weekly number of cigarettes and nicotine dependence, Switzerland 2010–2013.
Model 1 Model 2 Model 3
b 95% CI b 95% CI b 95% CI
Weekly number of cigarettes
Occasional smoker at baseline
E-cigarette use 13.00 9.02, 16.97 12.55 8.59, 16.50 9.88 6.37, 13.40
Time of assessment 7.41 5.97, 8.86 7.09 5.22, 8.97 6.06 4.44, 7.68
E-cigarette use by assessment –0.30 –6.16, 5.56 –0.77 –6.63, 5.09 0.11 –4.87, 5.10
Daily smoker at baseline
E-cigarette use 6.09 –2.76, 14.94 6.22 –2.58, 15.03 3.31 –2.94, 9.57
Time of assessment –6.79 –10.20, –3.39 –8.02 –12.90, –3.13 –5.03 –8.69, –1.38
E-cigarette use by assessment 3.32 –5.58, 12.22 3.05 –5.89, 12.01 –1.84 –9.02, 5.34
Nicotine dependence
Occasional smoker at baseline
E-cigarette use 0.26 0.03, 0.48 0.24 0.02, 0.46 – –
Time of assessment 0.11 0.04, 0.17 0.12 0.02, 0.21 – –
E-cigarette use by assessment –0.06 –0.34, 0.22 –0.08 –0.37, 0.20 – –
Daily smoker at baseline
E-cigarette use 0.16 –0.20, 0.52 0.17 –0.19, 0.53 – –
Time of assessment –0.23 –0.35, –0.11 –0.18 –0.37, 0.01 – –
E-cigarette use by assessment 0.29 –0.03, 0.61 0.28 –0.04, 0.61 – –
b = estimate; CI = confidence interval
Model 1 = time of assessment, e-cigarette, time of assessment by e-cigarette interaction
Model 2 = model 1 adjusted for age, highest achieved education, linguistic region
Model 3 = model 2 adjusted for nicotine dependence.
Estimate for e-cigarette use reflects the difference between vapers and nonvapers at baseline. Estimate for time of assessment reflects the difference between follow-up
and baseline in nonvapers. Estimate for e-cigarette by time of assessment interaction reflects the difference between estimate of time of assessment in nonvapers and
estimate of time of assessment in vapers.
crease in CC use. However, we stratified the analysis by
smoking status at baseline, assuming that nonsmokers at
baseline used ECs at baseline less often – if at all – than
occasional smokers, and that occasional users did so less
often than daily smokers. We did have longitudinal data on
smoking changes, and compared these between vapers and
nonvapers which,in our opinion, is indicative of whether
vapers – independent of whether they became vapers after
baseline or had already been vapers at baseline ‒ reduced
their smoking or stopped smoking. Nevertheless, conclu-
sions have to be drawn with this limitation in mind.
Clearly, as has been shown in general population studies on
emerging adulthood [1], among young men in Switzerland,
vapers were commonly dual users [26]. At follow-up, only
10.6% of vapers were nonsmokers, 28.3% were occasional
smokers and 61.0% were daily smokers. This is not a sur-
prise, as ECs are often used for harm reduction compared
with CC use, in situations where smoking CCs is prohib-
ited, or as an aid to quit smoking [6, 25, 27].
Among nonsmokers at baseline, only 1.1% were vapers at
follow-up, of which 50% became also CC users, but 13%
(n = 367) became CC users without vaping. There are in-
creasingly alarming claims about increasing rates of “ever-
EC-users”, particularly among young nonsmokers. Here
are a few recent examples among adolescents: the percent-
age of “never smokers” who reported ever having used
ECs reached 8.0% in Wales [16], and 15.8% of e-cigar-
ette users were never-smokers in North West England [28].
EC use among young (grade 6 grade 12) never-smokers in
the USA increased three-fold from 79000 to over 263000
between 2011 and 2013 [17]. However, these apparently
alarming results meant that 3% of all students were never-
smoking EC users in the Hughes et al. [28] study (15.5%
of 19.2% ever EC users), or 0.9% in the USA study [17].
When regular EC use was assessed, in both the USA study
and the Wales study [16], only 0.3% of regular EC users
were never-smokers. In addition, as stated by West et al.
[4] or McNeill et al. [5], increases in EC use were in some
Table 5: Negative binomial regression models of the number of attempts to stop smoking on e-cigarette use (measured at follow-up only),
stratified by cigarette smoking at baseline, Switzerland 2010–2013.
Model 1 Model 2 Model 3
IRR
(95% CI)
IRR
(95% CI)
IRR
(95% CI)
Occasional smoker at baseline
E-cigarette use 1.92
(1.32, 2.80)
1.88
(1.29, 2.73)
1.81
(1.24, 2.64)
Daily smoker at baseline
E-cigarette use 1.27
(0.94, 1.70)
1.28
(0.95, 1.72)
1.28
(0.95, 1.73)
CI = confidence interval; IRR = incidence risk ratio
Model 1 = e-cigarette
Model 2 = model 1 adjusted for age, highest achieved education, linguistic region
Model 3 = model 2 adjusted for nicotine dependence.
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countries accompanied by decreases in smoking rates, al-
though this has not always been the case [18]. Thus, among
young men in Switzerland as among youths and young
adults in most other countries, EC use was unlikely to instil
the renormalisation of smoking among nonsmokers [4, 5].
Although vaping was not very prevalent in general and par-
ticularly in baseline nonsmokers, the latter were 6 times
more likely to be occasional smokers and more than 12
times more likely to be daily smokers at follow-up when
vaping than when not vaping. Similarly, occasional
smokers at baseline were more than 50% less likely to be
nonsmokers at follow-up and more than twice as likely to
be daily smokers at follow-up when vaping than when not
vaping. Again, there may be a “reversed” causation that
higher dependence levels, related to lower quit rates, led to
a more prevalent use of EC. Occasional smokers may have
become more dependent (daily) smokers first, and then
started using ECs. However, we think it is fair to say that
even though EC use may not have been the cause for rather
unfortunate findings, EC use at least seemed not to have
had the beneficial effects of reducing smoking among oc-
casional smokers or of reducing the progression in smoking
among both former nonsmokers or occasional smokers.
Among daily smokers at baseline, no significant difference
could be found between vapers and nonvapers in the re-
duction from daily CC use to occasional CC use. Despite
the 0.42 odds ratio (in the adjusted model) for resuming
smoking abstinence, vapers were not significantly less
likely than nonvapers to stop smoking (95% CI 0.15–1.18).
Again, even though some baseline daily smokers were
vapers at baseline already, continued EC use would not
have been successful in reducing daily smoking. Moreover,
if daily smokers took up vaping between baseline and
follow-up, it did not help reduce smoking either. Our res-
ults were in line with a review on smoking cessation by
Grana et al. [1], as well as with more recent studies adjust-
ing for nicotine dependence as our study did [7, 14]. Ran-
domised trials, however, have shown that EC use is more
efficacious than nicotine patches when it comes to quit-
ting smoking [29] or nicotine-free e-cigarettes [30]. Sim-
ilarly, a recent real-world experiment [2] showed that EC
use is of more help with quitting than over-the-counter re-
placement therapy products or no aid. More specifically,
Biener et al. [27] found that intensive EC users were six
times more likely to quit smoking at follow-up for at least 1
month compared with EC nonusers or those who only tried
out the EC, whereas intermittent EC users showed no ef-
fect. This may mean that the only persons who may bene-
fit from EC use are the ones who use EC as a serious at-
tempt to quit or reduce smoking (e.g. by using them daily).
Other prospective real-word studies such as among callers
of quitlines [8], or cancer patients [31] enrolled in a to-
bacco treatment programme found lower cessation rates
for vapers compared with nonvapers. Unfortunately, des-
pite the large sample size, prevalence rates in the present
study were too small to distinguish between intensive and
intermittent EC use. As a result, we can only speculate
whether ECs were used by 20-year-old men primarily out
of curiosity [32] or in places where they were not allowed
to smoke conventional cigarettes, and not yet as a substitute
for smoking. Vapers, however, showed more quit attempts
than nonvapers in the present study, which was significant
for occasional smokers only. Thus, ECs may be used by
young people as an aid for quitting smoking. Indeed, al-
though they quit smoking less often, they report more quit
attempts. More quit attempts but less success in quitting
have also been reported in other studies [14, 33], including
in a USA study among 18‒25-year-olds [15]. The lack of
successful quit attempts may be related to the use of some-
what ineffective, first generation nicotine delivery devices.
The present study could not differentiate between the type
of ECs used, but will do so in subsequent waves.
Mixed models (table 4) showed that vapers smoked more
CCs and had higher nicotine dependence levels already at
baseline than nonvapers. Again, this demonstrated the need
for smoking patterns to be accounted for in research on EC
use. EC use may be beneficial provided that CC use is re-
duced or at least partly replaced with less harmful nicot-
ine products. In the International Tobacco Control Study,
vapers had significantly reduced the number of CCs
smoked compared with nonvapers, although there was no
significant difference in quitting smoking between vapers
and nonvapers [6]. This finding was supported by studies
in the review of Grana et al. [1]. However, other studies
have shown increases in CC use among EC users in com-
parison with nonvapers [14]. Grana et al. [7], adjusting for
nicotine dependence, found that EC use by smokers was
not followed by greater rates of quitting or by reduction in
cigarette consumption one year later. The present study lies
somewhere between the latter results, showing no differen-
tial effect between vapers and nonvapers.
Beside the caveat mentioned above, another limitation of
the present study is its restriction to men only. As Grana
et al. [1] or Collaco et al. [11] pointed out, it may well be
that trying out the EC is even more prevalent among wo-
men. Despite these limitations, and given our findings, we
find it difficult to argue how EC use by young Swiss men
could be considered to be predominantly beneficial. Even
though EC use was a consequence of heavier smoking after
baseline, the onset of EC use has not reduced the num-
ber of CCs smoked. Assuming that the onset of EC use
occurred already at baseline (a detail which was not ob-
served) in the present study, continued EC use does not
seem to have influenced smoking cessation rates positively.
Indeed, even though vaping at follow-up among baseline
nonsmokers was rare, vapers were more often smokers at
follow-up than nonvapers.
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